About
A venture studio built where the science, the regulator, and the buyer all are.
KaRama forms health technology companies in the Kingdom of Saudi Arabia and stays on their cap tables.
Purpose
Turn health technology into Saudi companies that can actually be bought from.
KaRama Venture Studio operates from the SFDA campus in Hittin, Riyadh. We originate company theses from unmet needs inside Saudi health systems, co-found the companies against them, capitalize them from our own balance sheet, and carry them through regulatory approval to a first Kingdom contract.
We are a principal, not an adviser and not an intermediary. We hold a founder's stake in every company on this site, taken at incorporation, and we stay.
Vision 2030
Aligned to the health sector transformation program, and useful to it.
The Health Sector Transformation Program set out to restructure how the Kingdom delivers and pays for care: clusters on commercial footing, prevention moved upstream, a domestic supply base for what the system buys.
The last of those is where a studio is useful. Localization targets are met by companies existing, not by intent. Every company we form is a Saudi entity, staffed here, procurable here, and cleared here.
Leadership
The people who do the forming.
In a studio, the operators are the product. A founder deciding whether to build with us is deciding about these people.
Justin Inniss
Co-Founder and Chief Investment Officer
Thirty years across New York capital markets, European asset management, and Gulf principal investment. Leads capital formation and portfolio strategy for the studio from Riyadh.
Name to confirm
Chief Executive Officer
Placeholder — replace with the CEO's name, photograph, and a two-line biography before launch.
Name to confirm
Head of Regulatory Affairs
Placeholder — the person who owns the SFDA relationship should be named here. For a studio, this is the most load-bearing biography on the site.
Name to confirm
Head of Company Formation
Placeholder — entity, cap table, and founding team recruitment.
Name to confirm
Head of Clinical Partnerships
Placeholder — cluster and Ministry of Health relationships.
Name to confirm
Chief Technology Officer
Placeholder — shared technical platform across the portfolio.
Partners
Who we work with, and in what capacity.
Each relationship below should be characterized precisely before launch. Ambiguous logo walls invite the wrong question from exactly the counterparties you want.